Description
Deferasirox Dispersible is available in India.
Deferasirox Dispersible is the salt name for the drug sold under the brand name Asunra.
Deferasirox is used to remove excess iron from the body in patients who have had too many blood transfusions and in patients with non-transfusion dependent thalassemia syndromes. Deferasirox is an iron chelator (binder). It combines with iron in the blood.
Who is the CFA, distributor, and retailer for Asunra (Deferasirox Dispersible) Tablets in India?
Aark Pharmaceuticals is an authorized distributor, CFA (Carry and Forward Agent), and retailer for Asunra (Deferasirox Dispersible) Tablets in India. It is marketed by Novartis India Ltd. Aark claims to provide 100% authentic, cold-chain managed medicines. Aark supplies a wide range of Novartis products, including advanced cancer treatments.
The company serves hospitals, clinics, and patients across India, including major cities like Bangalore, Surat, Kolkata, Indore, Nagpur, Patiala, Srinagar, Ahmedabad, Osmanabad, Mumbai, Pune, Amaravati, Itanagar, Dispur, Patna, Raipur, Panaji, Gandhinagar, Chandigarh, Shimla, Ranchi, Bengaluru, Thiruvananthapuram, Imphal, Shillong, Aizawl, Kohima, Bhubaneswar, Jaipur, Gangtok, Chennai, Hyderabad, Coimbatore, Kochi, Kollam, Agartala, Lucknow, Dehradun, Gairsain, Aizawal, Aurangabad, Barshi, Karungapally, Pondichery, Punjab, Delhi, New Delhi, Agra, Kanpur, Gurugram, Alwar, Mathura, Panipat, Faridabad, Noida, Sonipat, Rohtak, Karnal, Ambala, Ghaziabad, Wardha, Bhopal, Manipur, Mizoram, Sikkim, Tripura, Arunachal, Meghalaya, Nagaland, Pasighat, Cachar, Dibrugarh, Kamrup.
How much do Asunra Tablets cost in Delhi, India?
Prices may vary based on your prescribed treatment plan. For accurate and the most cost-effective pricing on your prescription-recommended product, please contact Aark Pharmaceuticals
Contact Person: Ms. Himanshi
Address: S-14, Ground & Ist Floor, Green Park Extn., New Delhi-110016.
Do you offer any discounts?
Yes. Based on availability, prices may vary based on your prescribed treatment plan. Please ask for the best current price.
NEWS / Updates
- Ali Taher, Amal El-Beshlawy, Mohsen S Elalfy, Kusai Al Zir, Shahina Daar, Dany Habr, Ulrike Kriemler-Krahn, Abdel Hmissi, and Abdullah Al Jefri. Uses of Deferasirox. National Institute of Health. NIH National Centre for Biotechnology Information. Pubmed.gov. June 2009. [Accessed on 20th June 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2730551/
- Novartis Pharmaceuticals UK Ltd. Electronic Medicines Compendium (EMC). [Revised in March 2021] [Accessed on 20th June 2022] https://www.medicines.org.uk/emc/files/pil.4329.pdf
- Mylan Pharmaceuticals Limited. European Medical Agency (EMA). [Revised in September 2019] [Accessed on 20th June 2022] https://www.ema.europa.eu/en/documents/product-information/deferasirox-mylan-epar-product-information_en.pdf
- Novartis Pharma Stein AG. U.S. Food & Drug Administration. [Revised in October 2013] [Accessed on 20th June 2022] https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021882s019lbl.pdf
- Deferasirox. Accord Healthcare Polska Sp.z.o.o. [Revised in December 2021 [Accessed on 20th June 2022] https://cdn.accord-healthcare.com/ie/public/pil/eu_deferasirox_accord_ema-combined-h-5156-en-ib04_version4_-_pil_0.pdf
- Zydus Pharmaceuticals (USA) Inc. Deferasirox. [Revised in August 2021 [Accessed on 20th June 2022] https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4af5bc9e-3e09-4dfd-8cc8-7677953c9c7c
Written By
Mr. Sandeep Tomar (D. pharma)
Last updated
12 November 2025 AM (IST)
